ClinicalTrials.Veeva

Menu

Ultrasonographic Fetal Soft Markers and Aneuploidy

Cairo University (CU) logo

Cairo University (CU)

Status

Completed

Conditions

Soft Markers

Treatments

Device: Midtrimester anomaly scan
Genetic: Fetal Karyotyping

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to investigate the prevalence of soft markers which will be identified during a second trimester ultrasound. Secondary aims were to estimate the association between the soft markers and trisomies 13, 18 and 21 as well as the effect on the number of invasive tests will be performed.

Enrollment

100 patients

Sex

Female

Ages

20 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. pregnant woman between (16-24) weeks of gestation.
  2. singelton pregnancy.

Exclusion criteria

  1. Multiple pregnancies.
  2. Mental condition rendering the patients unable to understand the nature and scope of the study.

Trial design

100 participants in 1 patient group

16-24 weeks Pregnant womes
Description:
Pregnant Women at (16-24) weeks of gestation for mid trimester anomaly scan with one sonographic fetal soft marker or more.
Treatment:
Device: Midtrimester anomaly scan
Genetic: Fetal Karyotyping

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems